Previous Article | Next Article ![]()
Eukaryotic Cell, December 2007, p. 2206-2213, Vol. 6, No. 12
1535-9778/07/$08.00+0 doi:10.1128/EC.00176-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Kimberly Prohaska,
and
Noreen Williams*
Department of Microbiology and Immunology and The Witebsky Center for Microbial Pathogenesis and Immunology, 253 Biomedical Research Building, University at Buffalo, Buffalo, New York 14214
Received 16 May 2007/ Accepted 21 September 2007
|
|
|---|
|
|
|---|
In previous work from our laboratory, two Trypanosoma brucei RNA binding proteins, p34 and p37, were identified and characterized (39, 40). The only major difference between them is an 18-amino-acid insert located within the amino terminus of p37 that is absent in p34. These proteins contain two RNA binding domains (RBD) within the central coding region, and they have been shown to interact with 5S rRNA (31). In addition to the interaction with 5S rRNA, p34 and p37 have been found to interact with a family of nucleolar phosphoproteins, NOPP44/46 (30). These abundant proteins have been identified and characterized by M. Parsons and colleagues (9, 10, 27, 29). An interaction(s) between p34 and p37 and NOPP44/46 was mapped through yeast two-hybrid analysis and protein affinity chromatography and was shown to be mediated via the RNA binding domain of p34 and p37 (30). Thus, the RBD region of p34 and p37 serves to mediate a protein-RNA interaction with 5S rRNA as well as the protein-protein interaction with the NOPP44/46 proteins. At this time, we do not know whether these interactions are cooperative or competitive.
Here, we employ a T. brucei cell line expressing RNA interference (RNAi) that specifically targets both p34 and p37 (19) to further examine the cellular role of the interaction between p34 and p37 and the NOPP44/46 proteins.
|
|
|---|
Antibodies. Antibodies utilized were the following: p34/p37 polyclonal antiserum (39), NOPP44/46 monoclonal antiserum (29), and NOPP44/46 peptide antibody (raised to the peptide CEDMESYGVPPKRGGKS; Bethyl Laboratories); antiserum to T. brucei phosphoglycerate kinase (28); polyclonal antiserum to the T. brucei RNA polymerase II C-terminal domain (9); anti-XpoI (6), polyclonal antiserum to the T. brucei poly(A) binding protein (PABP); and β-tubulin monoclonal antibody (Chemicon).
Nuclear extract preparation and sucrose gradient analysis. Nuclear extracts were prepared (32) from wild-type cells and p34/p37 clonal RNAi cells at 2 days postinduction of dsRNA expression. Nuclear extracts (either 0.1 or 1.0 mg total protein as determined by the Bradford method) were applied to a continuous sucrose gradient (10 to 30%) and sedimented (31). Total protein from gradient fractions was precipitated with trichloroacetic acid (TCA), resolved on a 12% sodium dodecyl sulfate (SDS)-polyacrylamide gel, and transferred to a nitrocellulose membrane (Schleicher & Schuell). Western blot analysis was performed with antibodies directed against p34 and p37 or the NOPP44/46 proteins.
Isolation of trypanosome nuclei. Nuclei were isolated from wild-type cells and p34/p37 RNAi cells as described elsewhere (33). Briefly, 2.5 x 1010 procyclic cells were pelleted and resuspended in 8% polyvinylpyrrolidone (PVP; Sigma) containing 0.05% Triton X-100 (Sigma), 5 mM dithiothreitol (DTT), mammalian protease inhibitor mixture (Sigma), and solution P (100 mg phenylmethylsulfonyl fluoride, 2 mg pepstatin A in 5 ml of ethanol). Cells were homogenized and passed through a 25-gauge needle. The lysate was underlaid with 0.3 M sucrose in 8% PVP, solution P, 1 mM DTT, and protease inhibitor mixture and sedimented at 11,000 x g. The resulting top layer containing the cytoplasmic material was stored at –80°C. The pellet containing the crude nuclear extract was resuspended in 8 ml of 2.1 M sucrose in 8% PVP, DTT, protease inhibitor cocktail, and solution P (final volume containing approximately 2 x 1010 cell equivalents). A 12-ml aliquot of this mixture was applied to a discontinuous gradient in an SW28 tube (bottom to top, 8 ml 2.3 M sucrose-PVP, 8 ml 2.1 M sucrose-PVP, 8 ml 2.01 M sucrose-PVP) and sedimented at 100,000 x g for 2 h at 4°C. Nuclei were recovered from the 2.1/2.3 interface. The protein concentration of the cytoplasmic and nuclear isolates was determined using the Bio-Rad RC DC protein assay.
Analysis of protein steady-state levels and cellular distribution. Total cellular protein was prepared from an equivalent number (5 x 106) of wild-type cells and cells expressing p34/p37 dsRNA by resuspension in SDS-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer (16) and boiling for 5 minutes. Half of each sample was electrophoresed in two separate 12% SDS-PAGE gels, followed by transfer to nitrocellulose membranes and Western blot analysis (39). Each pair was analyzed using NOPP44/46 monoclonal antiserum or p34/p37 polyclonal antiserum for one blot and β-tubulin antibody (Chemicon) for the other blot as an internal loading control. Densitometric analysis was performed using a GS-700 imaging densitometer in combination with the Multi-Analyst software (Bio-Rad) with the corresponding wild type as the reference.
For analysis of protein cellular distribution, 25 µg of cytoplasmic and purified nuclear extracts from wild-type and p34/p37 RNAi cells was analyzed by Western blot analysis as described above.
Analysis of mRNA steady-state and stability assays. Total RNA was isolated from 5 x 106 wild-type or p34/p37 RNAi cells using TRIzol reagent (Invitrogen). Serial dilutions of total RNA were resolved by electrophoresis through a 2% agarose-formaldehyde gel and transferred to a nylon membrane (Schleicher & Schuell). Northern blot analysis was performed using oligonucleotide probes as previously described (31, 39), and the blots were processed for subsequent analysis (3). Oligonucleotides directed against small subunit (SSU; 18S) and large subunit (LSU; 28S) rRNA were utilized as loading controls. The oligonucleotide probe used to detect the presence of NOPP44/46 mRNA was the U-3 primer 5'-CGCGTCAATTCCTTCATTGTCCT-3' (10).
For analysis of mRNA stability, actinomycin D (10 µg/ml; Sigma) was added to wild-type and p34/p37 RNAi cells, after which total RNA was isolated at the indicated time points. For each sample, 5 µg of total RNA was resolved through a 2% agarose-formaldehyde gel and examined by Northern blot analysis as above. Densitometric analysis for both steady-state and stability assays was performed as described above.
Cellular fractionation for immune capture and LMB experiments. Wild-type and p34/p37 RNAi cells were grown to the appropriate density (1 x 106 cells/ml and 1 x 108 cells/ml for leptomycin B [LMB] and immune capture [IC] experiments, respectively), after which they were fractionated into nuclear and cytoplasmic extracts (32). Protein concentration was quantified using the Bradford method as indicated elsewhere (2).
IC and Western blot experiments. A 500-µg aliquot of wild-type and p34/p37 RNAi nuclear extract was used for each IC sample. Prior to IC, 100 µl Dynabeads (Dynal) was cross-linked to anti-XpoI antibody (6). Cross-linking was performed as per the manufacturer's instructions. As a negative control, no antibody was added to one reaction mixture to control for proteins interacting nonspecifically with the beads. Following cross-linking, nuclear extracts were added to the beads and incubated overnight at 4°C. Supernatants were collected from the experimental reaction mixtures, and beads were washed five times with phosphate-buffered saline (PBS). The beads from each reaction mixture were resuspended in SDS-PAGE sample buffer and boiled for 5 min. Samples were subjected to SDS-polyacrylamide gel electrophoresis for 16 h at 125 V. To detect the presence of p34 and p37 proteins in the IC reaction mixtures, the proteins were transferred to a nitrocellulose membrane and blocked in 10% nonfat dry milk followed by incubation with anti-p34/p37 polyclonal antiserum. Goat anti-rabbit antibody conjugated to horseradish peroxidase was used as the secondary antibody, and proteins were detected using SuperSignal West Pico chemiluminescent substrate (Pierce). In order to detect the presence of NOPP44/46 in these samples, Western blots were stripped with buffer containing 0.2 M glycine and 0.05% Tween 20 at a final pH of 2.5 at 80°C for 30 min (S. Howell, Western protocol [http://cancer.ucsd.edu/howelllab/Western.html]). NOPP44/46 were detected as described above using monoclonal anti-NOPP44/46 antiserum.
Sequential immune capture experiments. Immune capture experiments using anti-XpoI were performed as described above. Following incubation with nuclear extracts, beads were washed with PBS and bound proteins were eluted using PBS with 1% SDS, 50 mM DTT, and 10% β-mercaptoethanol (17). Reaction mixtures were boiled for 5 min, diluted to a 100-µl total volume, and allowed to renature at room temperature. Diluted samples were used for p34 and p37 immune captures as described above. Samples were subjected to SDS-polyacrylamide gel electrophoresis and Western blot analysis probing for NOPP44/46.
LMB experiments. A total of 2.0 x 106 wild-type procyclic cells were treated with LMB (a gift from D. Campbell, UCLA) at a final concentration of 0.001 ng/cell, and aliquots of 1.0 x 106 cells were taken at 0, 12, 24, and 48 h. Following treatment, cells were fractionated into nuclear and cytoplasmic extracts as described above. The equivalent of 1.0 x 106 cells for each sample was subjected to SDS-PAGE using 5 to 20% gradient gels for 16 h at 150 V. The gel was cut in half at the 60-kDa marker band, and each half was transferred to a nitrocellulose membrane. Western blot analysis to detect the presence of NOPP44/46 (lower half of the gel) in each sample was performed as described above. For a loading control, the upper half of the gel was used for Western blot analysis against the RNA polymerase II C-terminal domain. Densitometric analysis was performed as described above.
|
|
|---|
Since p34 and p37 and the NOPP44/46 proteins are predominantly localized to the nucleus and nucleolus, respectively, we first investigated this interaction in nuclear extracts, which contain both nuclear and nucleolar material. To determine whether loss of p34 and p37 disrupts NOPP44/46-containing complexes, we examined nuclear extracts that were sedimented through a continuous 10 to 30% sucrose gradient. Figure 1 is representative of five separate experiments. Two overlapping peaks that contain NOPP44/46 were consistently detected in sucrose gradient fractions of nuclear extracts from wild-type procyclic cells (Fig. 1A, bottom panel). The first of these peaks comigrates with p34 and p37 (fractions 18 to 22), while the second peak does not (fractions 24 and 26). In the p34/p37 RNAi cell extracts, the first peak of NOPP44/46, which previously migrated with p34 and p37, was lost (Fig. 1B, lower panel, fractions 18 and 20). The second peak of NOPP44/46 proteins, which did not comigrate with p34 and p37, was still present. This suggests that, in wild-type cells, p34 and p37 and the NOPP44/46 proteins are part of a higher-molecular-weight complex(es) and that loss of p34 and p37 leads to disruption or alterations within this complex(es). We also observed that the abundance of the NOPP44/46 proteins in p34/p37 RNAi nuclear extracts was significantly increased. For comparison purposes, in the bottom panel of Fig. 1B, 0.1 mg (compared to 1.0 mg in Fig. 1A, bottom panel) of p34/p37 RNAi nuclear extracts had to be used for sedimentation analysis to allow for comparable exposures of these blots. Hence, these experiments demonstrate that an increase in nuclear NOPP44/46 protein levels occurred in the absence of p34 and p37.
![]() View larger version (37K): [in a new window] |
FIG. 1. Sucrose gradient sedimentation analysis of NOPP44/46. Nuclear extracts were prepared from wild-type procyclic cells (A) and cells expressing p34/p37 dsRNA (B). The amount of nuclear extract indicated was sedimented through a continuous 10 to 30% sucrose gradient. Fractions were collected and TCA precipitated. Western blot analysis was performed to detect the positions of p34 and p37 as well as the NOPP44/46 proteins. Fraction 2 designates the bottom of the gradient. The positions of 5S rRNA, small subunit (18S) rRNA, and large subunit (28S) rRNA markers are indicated.
|
![]() View larger version (36K): [in a new window] |
FIG. 2. Analysis of NOPP44/46 protein levels within nuclear extracts. The indicated amount of nuclear extracts (NE) from either wild-type or p34/p37 RNAi cells was analyzed by Western blotting using antibodies directed against p34 and p37 (upper panel), NOPP44/46 (middle panel), and a β-tubulin loading control (lower panel).
|
![]() View larger version (35K): [in a new window] |
FIG. 3. Analysis of NOPP44/46 mRNA steady-state levels within wild-type and p34/p37 RNAi cells. Total RNA was isolated from an equivalent number (5 x 106) of wild-type and p34/p37 RNAi cells. Northern blot analysis was performed using oligonucleotide probes specific to NOPP44/46 mRNA (upper panel), SSU rRNA (middle panel), and LSU rRNA (lower panel). The left panels include dilutions of total RNA from wild-type cells, and the right panels include dilutions of total RNA from p34/p37 RNAi cells.
|
|
View larger version (23K): [in a new window] |
FIG. 4. Analysis of NOPP44/46 mRNA stability within wild-type and p34/p37 RNAi cells. Actinomycin D was added to a final concentration of 10 µg/ml. Total RNA was isolated at increasing time points, and 5 µg of each sample was analyzed. Probes specific to NOPP44/46 mRNA (upper panel) and SSU rRNA (lower panel) were utilized in Northern blot analyses.
|
![]() View larger version (63K): [in a new window] |
FIG. 5. Analysis of NOPP44/46 total protein levels. Total cellular protein was prepared from an equivalent number (5 x 106) of wild-type and p34/p37 RNAi cells. In each experiment, half of the cell suspension was applied to two separate SDS-polyacrylamide gels, and samples were processed for Western blot analysis, probing for either p34 and p37 (top panel) or NOPP44/46 (middle panel). A representative blot for the β-tubulin loading control is shown (lower panel).
|
![]() View larger version (59K): [in a new window] |
FIG. 6. NOPP44/46 localization in p34/p37 RNAi cells. Nuclear extracts were prepared from wild-type and p34/p37 RNAi cells. With the amount of extract indicated, samples were separated using SDS-PAGE and processed for Western blot analysis. (A) Results from nuclear extracts; (B) results from cytoplasmic extracts. The presence of p34 and p37 proteins, NOPP44/46, phosphoglycerate kinase (PGK; a cytoplasmic marker), and the RNA polymerase II large subunit (CTD; a nuclear marker) were detected as indicated.
|
![]() View larger version (32K): [in a new window] |
FIG. 7. Motif and sequence analysis of p34 and p37 proteins. (A) Motif maps of the p34 and p37 proteins, including locations of NLS and NES. APK, alanine, proline, lysine-rich domain; RBD, RNA binding domain; KKDX, lysine, lysine, aspartic acid, and "X" repeat motif. (B) Nuclear export signal sequences shown with the consensus sequence. Similar and identical residues between T. brucei p34 and p37 and T. cruzi UBP-1 are underlined. Spaces were introduced to allow for alignment of conserved leucine residues.
|
![]() View larger version (34K): [in a new window] |
FIG. 8. NOPP44/46 associate with exportin 1 through an interaction with p34/p37. Wild-type and RNAi cells were fractionated into cytoplasmic and nuclear extracts. A 500-µg aliquot of nuclear extract was used for subsequent immune capture of exportin 1. Samples were subjected to SDS-PAGE and Western blot analysis to detect p34 and p37 (upper panel). Membranes were stripped and reprobed for detection of NOPP44/46 (middle panel). As a control, membranes were stripped again and reprobed for PABP (lower panel). B, IC beads-alone control; NE, 50 µg nuclear extract; P, IC pellet fraction; S, IC supernatant fraction.
|
p34, p37, NOPP44/46, and exportin 1 exist in a common complex. Single immune capture experiments demonstrated that p34 and/or p37 is required for the association of NOPP44/46 with exportin 1. Thus, we wished to determine whether p34 and/or p37, NOPP44/46, and exportin 1 form a molecular complex. The results shown in Fig. 9 are representative of five separate experiments. We performed single IC experiments to capture p34 and p37 (Fig. 9, left panel, p34/p37 IC) and, in a separate experiment, exportin 1 (Fig. 9, left panel, XpoI IC). These experiments confirmed the interaction between NOPP44/46 and p34 and p37, and also between NOPP44/46 and exportin 1 (Fig. 9, compare IC-P lanes between p34/p34 IC and XpoI IC). Sequential immune capture experiments, capturing exportin 1 and then p34 and p37, demonstrated that a subset of nuclear NOPP44/46 are in complex with p34 and/or p37 and with exportin 1 simultaneously (Fig. 9, right panel). This may not represent the entire population of NOPP44/46 involved in this complex, as more protein was released from the beads upon a second elution (Fig. 9, right panel).
|
View larger version (15K): [in a new window] |
FIG. 9. p34 and/or p37, exportin 1, and NOPP44/46 are involved in a common complex. Procyclic nuclear extracts were used to perform exportin 1 immune capture assays. The first capture was eluted using SDS, DTT, and β-mercaptoethanol. Eluate was renatured and used for subsequent immune capture of p34 and p37. B, IC beads-alone control; NE, 50 µg nuclear extract; P, IC pellet fraction; S, IC supernatant fraction; P2, IC second elution.
|
NOPP44/46 proteins accumulate in the nucleus upon treatment of wild-type procyclic cells with leptomycin B. Since NOPP44/46 are associated with exportin 1 in a p34- and/or p37-dependent manner, we hypothesized that they are subsequently transported out of the nucleus. To determine whether this is the case, we treated wild-type cells with LMB, a specific inhibitor of the exportin 1 pathway. LMB acts to inhibit exportin 1-dependent nuclear export by irreversibly modifying a conserved cysteine residue required for the interaction with NES-containing cargoes (23). Cells were treated with LMB at a final concentration of 0.001 ng/cell, as previously described for T. brucei (38). Cells were left untreated (control) or treated for 12, 24, or 48 h, after which cells were fractionated into nuclear and cytoplasmic extracts. Extracts were subjected to SDS-PAGE for subsequent Western blot analysis of NOPP44/46. As shown in Fig. 10 (representative of four separate experiments), we detected a steady increase in nuclear NOPP44/46 protein abundance throughout the time course of the experiment (right panel), whereas cytoplasmic NOPP44/46 levels remained relatively constant (left panel). Using exposures from each experiment in the linear range, there was an average 5.5-fold ± 0.3-fold increase in nuclear NOPP44/46 protein levels after 48 h of treatment. These results correlate with those shown in the middle panels of Fig. 2, where there was an increase in nuclear NOPP44/46 proteins in the absence of p34 and p37. As a control, we used an antibody directed against the large subunit of RNA polymerase II (Fig. 10, bottom panel), since it does not contain a nuclear export signal. The levels of this protein remained steady throughout the time course of the experiment, demonstrating that the increase in nuclear NOPP44/46 abundance is specific to their interaction with exportin 1. Together, our results demonstrate that NOPP44/46 exit the nucleus through an exportin 1-dependent mechanism, which is mediated by their interaction with p34 and/or p37.
![]() View larger version (16K): [in a new window] |
FIG. 10. Localization of NOPP44/46 upon treatment of wild-type procyclic cells with leptomycin B. A total of 1.0 x 106 cells/reaction mixture were left untreated or treated with LMB for the indicated time points at a final concentration of 0.001 ng/cell. Cells were fractionated into nuclear and cytoplasmic extracts and subjected to SDS-PAGE. Western blot analyses were performed to detect NOPP44/46 (upper panel) and the large subunit of RNA polymerase II (CTD) (lower panel).
|
|
|
|---|
Results presented here indicate that loss of p34 and p37 proteins leads to the disruption of a cellular complex(es) that normally contains these proteins. In sucrose gradient analysis of RNAi cell nuclear extracts, an upward shift in the sedimentation profile of the NOPP44/46 proteins occurred (Fig. 1B, bottom panel), indicating that loss of p34 and p37 resulted in alterations within a complex(es) that contains both proteins.
Upon induction of p34/p37 dsRNA, an increase in nuclear NOPP44/46 protein levels occurred compared to wild type (Fig. 2, middle panels). A 12-fold increase in NOPP44/46 protein levels was observed upon loss of p34 and p37 (Fig. 6A, second panel), suggesting that p34 and p37 regulate NOPP44/46 expression. We detected no change in the abundance or stability of NOPP44/46 transcript in the RNAi cells (Fig. 3 and 4), indicating that p34 and p37 do not regulate NOPP44/46 transcript expression. Unexpectedly, when we examined the overall cellular protein levels of NOPP44/46, we found that they remained unchanged in p34/p37 RNAi versus wild-type cells (Fig. 5). Taken together with our cellular fractionation results (Fig. 2 and 6), this strongly suggests that p34 and p37 act to regulate NOPP44/46 cellular localization.
Previous studies using immunoelectron microscopy and immunofluorescence analyses have indicated that NOPP44/46 are localized to the nucleolus (10). However, this does not preclude the possibility that a small subset of these proteins rapidly shuttle out of the nucleolus/nucleus, since their cytoplasmic abundance may be below the level of detection with these methods. The NOPP44/46 proteins do not contain a nuclear localization or export signal sequence, although their amino-terminal unique (U) sequence has been shown to be required for nucleolar localization. This suggests that the cellular localization of NOPP44/46 may be dependent on other nuclear and/or nucleolar proteins.
In p34 and p37, the last nine residues of the second RBD comprise a putative NES sequence (Fig. 7A), which fits the consensus sequence found in the human immunodeficiency virus type 1 Rev protein (13). It is also very similar to the NES found in the T. cruzi RNA binding protein TcUBP-1 (Fig. 7B) (12), indicating a sequence conservation within trypanosomes. Figure 8 demonstrates that p34 and p37 interact with the nuclear export factor exportin 1. A variety of cellular components undergo exportin 1-dependent nuclear export. These include the large (60S) and small (40S) ribosomal subunits, many cellular proteins, several U snRNAs, all rRNAs, and a subset of mRNAs (7, 15, 20, 26, 36, 37). Exportin 1 has been identified in trypanosomes and is indicated as having a role in the nuclear export of spliced leader RNA in T. brucei as well as a subset of mRNA in T. cruzi (6, 38).
The p34 and p37 proteins appear to act as adapter proteins allowing for the export of the NOPP44/46 proteins out of the nucleus in an exportin 1-dependent manner. Examples of proteins and protein complexes that depend on adapter proteins for their association with exportin 1 and subsequent nuclear export include the mammalian 14-3-3 proteins and the yeast 60S ribosomal subunit (5, 20). The 60S ribosomal subunit is exported to the cytoplasm via the exportin 1 nuclear export pathway, which requires the nonribosomal adapter protein Nmd3p (20). Nmd3p acts to provide the nuclear export signal to mediate the association between the 60S ribosomal subunit and exportin 1. It is important to note that, in addition to Nmd3p, several other nonribosomal factors are required for nuclear export of the 60S ribosomal subunit, including Nop53p, Nug1p, and Nug2p (1, 35). This suggests that nuclear export may involve large complexes and that it is regulated by several different types of proteins. Thus, p34 and p37, possibly in concert with unidentified factors, may act in a similar manner to regulate NOPP44/46 cellular localization. This is further supported by the p34/p37 RNAi immune capture results, which demonstrated the loss of the NOPP44/46-exportin 1 association in the absence of p34 and p37 (Fig. 8, right middle panel). The accumulation of NOPP44/46 in the nucleus following LMB treatment (Fig. 10) further suggests that NOPP44/46 are exported from the nucleus via exportin 1. Together, these data suggest that p34 and p37 may function as a control mechanism to shuttle excess NOPP44/46 proteins out of the nucleus or, alternatively, they may serve to regulate the nuclear export of a larger complex containing the NOPP44/46 proteins.
We have previously established that p34 and p37 associate with 5S rRNA (31), a component of the 60S ribosomal subunit. Recent work from this laboratory using the same p34/p37 RNAi cells has demonstrated a dramatic decrease in the levels of 5S rRNA, in addition to disruption of a cellular complex(es) containing 5S rRNA (19). These results suggest an important role for p34 and p37 in stabilizing 5S rRNA. The loss of 5S rRNA in these cells leads to a significant decrease in protein synthesis efficiency, which appears to be the result of a defect in the assembly the 60S ribosomal subunits into the 80S complex (19). At this time, we do not know whether the disrupted complex(es) in the p34/p37 RNAi cells contains both NOPP44/46 and 5S rRNA or whether they are separate and distinct complexes. The Parsons laboratory has recently shown that NOPP44/46 are involved in the later stages of 60S ribosomal subunit biogenesis (21). Experiments utilizing NOPP44/46 RNAi cells have demonstrated aberrant processing of pre-60S rRNA, disruption of 60S assembly, and cell death (21). Incorporation of 5S rRNA is one of the final steps in the assembly pathway of the 60S ribosomal subunit (11). Thus, p34 and p37 may function to coordinate 5S rRNA incorporation into assembling pre-60S ribosomal subunits through an interaction with the NOPP44/46 proteins.
We do not currently know whether the interaction of p34 and p37 with 5S rRNA and the NOPP44/46 proteins reflects one common or two distinct roles for these proteins. Thus, these interactions could occur independently of one another. Overall, the results presented here indicate that the protein-protein interaction of p34 and p37 with NOPP44/46 plays an important role in NOPP44/46 protein cellular distribution, possibly in the context of a larger complex. Experiments are currently under way to more precisely define the components and function of this complex.
This work was supported by NIAID grant AI 41134 (to N.W. and W. T. Ruyechan) and NIH Predoctoral Training Grant T32AI07614 for the support of K.H. and K.P.
Published ahead of print on 5 October 2007. ![]()
Kristina Hellman and Kimberly Prohaska contributed equally to this work. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»